• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本左主干冠状动脉疾病的最新经皮冠状动脉介入治疗

State-of-the-art percutaneous coronary intervention for left main coronary artery disease in Japan.

作者信息

Warisawa Takayuki, Sonoda Shinjo, Yamaji Kyohei, Amano Tetsuya, Kohsaka Shun, Natsuaki Masahiro, Tsujita Kenichi, Hibi Kiyoshi, Kobayashi Yoshio, Kozuma Ken

机构信息

Department of Cardiology, NTT Medical Center Tokyo, Tokyo, Japan.

Department of Cardiovascular Medicine, Saga University, 5-1-1, Nabeshima, Saga, 849-8501, Japan.

出版信息

Cardiovasc Interv Ther. 2024 Oct;39(4):386-402. doi: 10.1007/s12928-024-01030-4. Epub 2024 Jul 30.

DOI:10.1007/s12928-024-01030-4
PMID:39078544
Abstract

Percutaneous coronary intervention for left main coronary artery disease (LM-PCI) represents a high-risk yet life-saving procedure that has evolved significantly over the years. This review outlines the current state-of-the-art practices for LM-PCI in Japan in detail, emphasizing the integration of coronary physiology and intracoronary imaging alongside with evidence-based standardized technique using latest drug-eluting stents. These advancements enable precise lesion assessment, stent sizing, and optimal deployment, thereby enhancing procedural safety and efficacy. Despite discrepancies between current guidelines favoring coronary artery bypass grafting and real-world practice trends towards increased LM-PCI adoption, particularly in elderly populations with multiple comorbidities, careful patient selection and procedural planning are critical. Future perspectives include further refining LM-PCI through conducting randomized controlled trials integrating advanced techniques and addressing the issue of ostial left circumflex lesions and nationwide standardization of medical care for LM disease.

摘要

经皮冠状动脉介入治疗左主干冠状动脉疾病(LM-PCI)是一种高风险但能挽救生命的手术,多年来已取得显著进展。本综述详细概述了日本目前LM-PCI的先进技术,强调冠状动脉生理学和血管内成像与使用最新药物洗脱支架的循证标准化技术的整合。这些进展能够实现精确的病变评估、支架尺寸选择和最佳置入,从而提高手术的安全性和有效性。尽管目前的指南倾向于冠状动脉旁路移植术,而现实世界中LM-PCI的应用趋势有所增加,尤其是在患有多种合并症的老年人群中,但仔细的患者选择和手术规划至关重要。未来的展望包括通过开展整合先进技术的随机对照试验,进一步完善LM-PCI,解决左旋支开口病变问题,并在全国范围内实现LM疾病医疗护理的标准化。

相似文献

1
State-of-the-art percutaneous coronary intervention for left main coronary artery disease in Japan.日本左主干冠状动脉疾病的最新经皮冠状动脉介入治疗
Cardiovasc Interv Ther. 2024 Oct;39(4):386-402. doi: 10.1007/s12928-024-01030-4. Epub 2024 Jul 30.
2
Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.比较单纯血管造影方法与紫杉醇经皮冠状动脉介入治疗和心脏手术评分方法在左主干冠状动脉支架置入中的协同作用:系列 PRECOMBAT(使用依维莫司洗脱支架在左主干冠状动脉疾病患者中进行旁路手术与血管成形术的随机比较的首项研究)的汇总分析。
Circ Cardiovasc Interv. 2018 Jan;11(1):e005374. doi: 10.1161/CIRCINTERVENTIONS.117.005374.
3
Fix and pull technique for retrieval of intracoronary unexpanded-stent entrapment.冠状动脉内未扩张支架嵌顿的固定和取出技术。
Catheter Cardiovasc Interv. 2023 Aug;102(2):247-248. doi: 10.1002/ccd.30756. Epub 2023 Jun 27.
4
Dynamic assessment of the left main-left circumflex bending angle: Implications for ostial left circumflex artery in-stent restenosis after successful two-stent PCI.左主干-左旋支弯曲角度的动态评估:对成功进行双支架PCI术后左旋支开口处支架内再狭窄的意义
Int J Cardiol. 2023 May 1;378:11-19. doi: 10.1016/j.ijcard.2023.02.030. Epub 2023 Feb 15.
5
Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography.光学相干断层扫描观察无保护左主干病变后左旋支开口处西罗莫司洗脱支架与依维莫司洗脱支架血管反应的差异
Int J Cardiol. 2017 Mar 1;230:284-292. doi: 10.1016/j.ijcard.2016.12.122. Epub 2016 Dec 23.
6
Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.药物洗脱支架置入治疗无保护左主干冠状动脉疾病后,冠状动脉解剖结构和支架技术对长期预后的影响。
JACC Cardiovasc Interv. 2014 Jan;7(1):29-36. doi: 10.1016/j.jcin.2013.08.013. Epub 2013 Dec 11.
7
The Current State of Left Main Percutaneous Coronary Intervention.左主干经皮冠状动脉介入治疗的现状。
Curr Atheroscler Rep. 2018 Jan 17;20(1):3. doi: 10.1007/s11883-018-0705-2.
8
The impact of left circumflex coronary artery ostium stenosis on outcomes for patients after percutaneous coronary intervention for unprotected left main disease.左旋支冠状动脉开口狭窄对经皮冠状动脉介入治疗无保护左主干病变患者预后的影响。
Kardiol Pol. 2023;81(9):903-908. doi: 10.33963/KP.a2023.0156. Epub 2023 Jul 25.
9
Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.药物洗脱支架经皮冠状动脉介入治疗与旁路手术治疗 3 支血管病变或左主干病变患者的成本效益:紫杉醇药物洗脱支架与心脏手术(SYNTAX)试验的最终结果。
Circulation. 2014 Sep 30;130(14):1146-57. doi: 10.1161/CIRCULATIONAHA.114.009985. Epub 2014 Aug 1.
10
Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗无保护左主干冠状动脉疾病的比较
Am J Cardiol. 2017 Feb 15;119(4):520-527. doi: 10.1016/j.amjcard.2016.11.003. Epub 2016 Nov 16.

引用本文的文献

1
Sex Differences in State-of-the-Art Management for Left Main Disease.左主干病变的最新管理中的性别差异。
JACC Adv. 2025 Aug;4(8):102009. doi: 10.1016/j.jacadv.2025.102009.
2
The First-in-Man Technique of Drug Eluting and Perfusion Therapy for Left Main Coronary Artery Disease.左主干冠状动脉疾病的药物洗脱与灌注治疗的首例人体技术。
Catheter Cardiovasc Interv. 2025 Aug;106(2):978-987. doi: 10.1002/ccd.31621. Epub 2025 May 29.

本文引用的文献

1
Physiological Assessment with iFR prior to FFR Measurement in Left Main Disease.在左主干病变中,iFR 测量前的生理学评估。
Cardiovasc Interv Ther. 2024 Jul;39(3):241-251. doi: 10.1007/s12928-024-00989-4. Epub 2024 Apr 20.
2
Proximal optimization technique and percutaneous coronary intervention for left main disease: POTENTIAL-LM.近端优化技术与经皮冠状动脉介入治疗左主干病变:POTENTIAL-LM研究
Catheter Cardiovasc Interv. 2024 Feb;103(3):417-424. doi: 10.1002/ccd.30961. Epub 2024 Jan 31.
3
Impact of stent strut link location in proximal balloon edge dilation technique for bifurcation percutaneous coronary intervention.
支架支柱连接位置对分叉经皮冠状动脉介入治疗中近端球囊边缘扩张技术的影响。
Cardiovasc Interv Ther. 2024 Apr;39(2):137-144. doi: 10.1007/s12928-023-00981-4. Epub 2024 Jan 31.
4
Optimal Minimal Stent Area and Impact of Stent Underexpansion in Left Main Up-Front 2-Stent Strategy.左主干 upfront 2 支架策略中最优最小支架面积和支架扩张不足的影响。
Circ Cardiovasc Interv. 2024 Jan;17(1):e013006. doi: 10.1161/CIRCINTERVENTIONS.123.013006. Epub 2024 Jan 16.
5
Intravascular Ultrasound Optimization Criteria for Left Main Coronary Artery Stenting: In Pursuit of the Magic Numbers!左主干冠状动脉支架置入术的血管内超声优化标准:探寻神奇数字!
Circ Cardiovasc Interv. 2024 Jan;17(1):e013691. doi: 10.1161/CIRCINTERVENTIONS.123.013691. Epub 2024 Jan 16.
6
Clinical Benefit of Intravascular Imaging Compared With Conventional Angiography in Left Main Coronary Artery Intervention.血管内影像学与常规血管造影在左主干冠状动脉介入治疗中的临床获益比较。
Circ Cardiovasc Interv. 2023 Dec;16(12):e013359. doi: 10.1161/CIRCINTERVENTIONS.123.013359. Epub 2023 Nov 29.
7
CVIT 2023 clinical expert consensus document on intravascular ultrasound.2023 年心血管血管内超声临床专家共识文件
Cardiovasc Interv Ther. 2024 Jan;39(1):1-14. doi: 10.1007/s12928-023-00957-4. Epub 2023 Sep 1.
8
2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG.2022 年 ESC/EACTS 联合对 2018 年指南建议的回顾:低手术风险且适合 PCI 或 CABG 解剖结构的左主干冠状动脉疾病患者的血运重建。
Eur Heart J. 2023 Nov 1;44(41):4310-4320. doi: 10.1093/eurheartj/ehad476.
9
The ability of contemporary cardiologists to judge the ischemic impact of a coronary lesion visually.当代心脏病学家通过视觉判断冠状动脉病变的缺血影响的能力。
Cardiovasc Revasc Med. 2024 Feb;59:60-66. doi: 10.1016/j.carrev.2023.08.003. Epub 2023 Aug 12.
10
Deferred Versus Performed Revascularization for Left Main Coronary Disease With Hemodynamic Significance.有血流动力学意义的左主干冠状动脉疾病的延迟与即刻血运重建。
Circ Cardiovasc Interv. 2023 Jun;16(6):e012700. doi: 10.1161/CIRCINTERVENTIONS.122.012700. Epub 2023 Jun 20.